Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products in orthopedics, sports medicine and wound care, announced today that, on November 27, 2013, the Centers for Medicare and Medicaid Services released their proposed ruling for the reimbursement of...
Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting
Saturday, November 30, 2013
Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment